Colocalization of Thrombin, PAI-1, and Vitronectin in the Atherosclerotic Vessel Wall
- 1 April 2000
- journal article
- Published by Ovid Technologies (Wolters Kluwer Health) in Arteriosclerosis, Thrombosis, and Vascular Biology
- Vol. 20 (4), 1143-1149
- https://doi.org/10.1161/01.atv.20.4.1143
Abstract
The serine protease thrombin is a mitogen for vascular smooth muscle cells. To that end, thrombin cleaves the surface-exposed, protease-activated receptor type 1 (PAR-1), resulting in signal transduction and ultimately, proliferation of these cells. Regulation of thrombin activity in the human atherosclerotic vessel wall has not been studied in great detail, conceivably because the traditional plasma thrombin inhibitor, anti-thrombin III, is not encountered at this location. By using immunofluorescence confocal microscopy, we demonstrate that the antigens of thrombin, plasminogen activator inhibitor 1 (PAI-1), and vitronectin (Vn) colocalize in human neointimal atherosclerotic arterial tissue. Furthermore, it is shown by in situ reverse zymography that these specimens harbor the active form of PAI-1, which is the only configuration of PAI-1 capable of complexing with Vn and inhibiting serine proteases, eg, thrombin. Two different criteria were used to establish that neointimal atherosclerotic material contains active alpha-thrombin, namely, its ability to bind to the thrombin inhibitor hirudin and to convert the thrombin-specific chromogenic substrate S2238. The latter activity could be fully prevented by preincubation with the thrombin-specific inhibitor, phenyl-prolyl-arginyl-chloromethyl ketone. The thrombin concentration measured by conversion of the chromogenic substrate was 7 to 12 nmol/L in the vascular specimens studied. This concentration range suffices to activate the PAR-1 receptor on vascular smooth muscle cells and to cause neointimal proliferation. It is concluded that the human atherosclerotic arterial vessel wall provides conditions that favor a regulatory mechanism of thrombin activity by PAI-1/Vn complexes.Keywords
This publication has 32 references indexed in Scilit:
- Prothrombin-Related Antigens in Human Aortic IntimaSeminars in Thrombosis and Hemostasis, 1996
- Role of the thrombin receptor in development and evidence for a second receptorNature, 1996
- Elevated levels of plasminogen-activator inhibitor type 1 in atherosclerotic aortaJournal of Vascular Surgery, 1996
- Plasminogen Activator Inhibitor-1 and Vitronectin Promote the Cellular Clearance of Thrombin by Low Density Lipoprotein Receptor-related Proteins 1 and 2Published by Elsevier BV ,1996
- Immunocytochemical localization of endogenous anti-thrombin III in the vasculature of rat tissues reveals locations of anticoagulantly active heparan sulfate proteoglycans.Journal of Histochemistry & Cytochemistry, 1994
- Specific glycosaminoglycans support the inhibition of thrombin by plasminogen activator inhibitor 1Biochemistry, 1993
- Thrombin stimulates proliferation of cultured rat aortic smooth muscle cells by a proteolytically activated receptor.JCI Insight, 1993
- Thrombin receptor expression in normal and atherosclerotic human arteries.JCI Insight, 1992
- Thrombin neutralizes plasminogen activator inhibitor 1 (PAI-1) that is complexed with vitronectin in the endothelial cell matrix.The Journal of cell biology, 1991
- Functional interaction of plasminogen activator inhibitor type 1 (PAI-1) and heparinBiochemistry, 1991